1. Home
  2. NWBI vs NNNN Comparison

NWBI vs NNNN Comparison

Compare NWBI & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northwest Bancshares Inc.

NWBI

Northwest Bancshares Inc.

HOLD

Current Price

$13.34

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.65

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWBI
NNNN
Founded
1896
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
NWBI
NNNN
Price
$13.34
$25.65
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$13.67
N/A
AVG Volume (30 Days)
1.2M
73.0K
Earning Date
01-26-2026
04-28-2026
Dividend Yield
6.04%
N/A
EPS Growth
16.74
N/A
EPS
0.92
0.06
Revenue
$599,086,000.00
$6,920,153.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.77
N/A
P/E Ratio
$14.39
$410.25
Revenue Growth
20.28
N/A
52 Week Low
$10.75
$5.18
52 Week High
$13.62
$55.65

Technical Indicators

Market Signals
Indicator
NWBI
NNNN
Relative Strength Index (RSI) 64.05 44.80
Support Level $13.07 $22.10
Resistance Level $13.59 $34.00
Average True Range (ATR) 0.30 6.84
MACD 0.08 -0.40
Stochastic Oscillator 81.10 22.21

Price Performance

Historical Comparison
NWBI
NNNN

About NWBI Northwest Bancshares Inc.

Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: